Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This phenomenon...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-Driven Vaccine Clinical Trial Design Features and Associated Progress Patterns: An Analysis of 1618 Clinical Trials from 2012 to 2022.

Vaccines·2026
Same author

Clinical impact and cost-effectiveness of rapid versus non-rapid antiretroviral therapy initiation in HIV-positive men who have sex with men in China using modelling and 96-week multicenter cohort data.

Scientific reports·2026
Same author

Disease and Economic Burden Averted by Hib Vaccination in 160 Countries: A Machine-Learning Analysis.

Vaccines·2025
Same author

Cost-effectiveness analysis of blood cell separators in allogeneic hematopoietic stem cell transplantation: a perspective from the Chinese healthcare system.

International journal of technology assessment in health care·2025
Same author

Cost-benefit analysis of universal screening for HCV infection in China: a Markov modelling study.

BMC health services research·2025
Same author

Optimizing strategy for cervical cancer prevention in china: a comprehensive modeling analysis.

Cost effectiveness and resource allocation : C/E·2025

Related Experiment Video

Updated: Jul 12, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Externally anchored covariate completion improved target-population effect estimation in meta-analysis with

Lingyao Sun1, Mingye Zhao1, Dachuang Zhou1

  • 1Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, 211198 China.

Journal of Clinical Epidemiology
|July 9, 2026
PubMed
Summary
This summary is machine-generated.

Externally Anchored Covariate Completion for Meta-analysis (EACC-Meta) reduces bias in treatment effect estimation from incomplete aggregate data. This novel framework leverages external real-world data (RWD) for improved accuracy without individual participant data.

Keywords:
Covariate adjustmentEvidence synthesisExternal dataMeta-analysisSimulation studyTransportability

Related Experiment Videos

Last Updated: Jul 12, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Biostatistics
  • Epidemiology
  • Health Data Science

Background:

  • Aggregate data meta-analysis often suffers from missing covariate information, limiting generalizability.
  • Estimating target-population treatment effects from aggregate data is challenging without individual participant data (IPD).
  • Real-world data (RWD) offers potential for supplementing incomplete aggregate data in meta-analyses.

Purpose of the Study:

  • To develop and evaluate the Externally Anchored Covariate Completion for Meta-analysis (EACC-Meta) framework.
  • To enable target-population treatment effect estimation using aggregate data and external RWD.
  • To assess EACC-Meta's performance against conventional meta-analysis methods.

Main Methods:

  • A Monte Carlo simulation study was conducted for target-population meta-analysis with incomplete aggregate data.
  • Binary outcomes were generated using a probit model with four binary covariates, including effect modifiers.
  • EACC-Meta was compared to fixed-effect and random-effects meta-analysis under various transport intensities and data scenarios.

Main Results:

  • EACC-Meta demonstrated consistently lower bias and root mean squared error compared to conventional meta-analysis.
  • The advantage of EACC-Meta increased with greater transport shift, especially when key effect modifiers were included.
  • Conventional methods showed poor coverage under high transport, while EACC-Meta maintained higher coverage, though sometimes below nominal levels.

Conclusions:

  • EACC-Meta effectively addresses missing data limitations in aggregate data evidence synthesis.
  • The framework provides a transparent method for estimating treatment effects in non-trial populations.
  • Integrating external structural information from RWD enhances the utility of aggregate data meta-analysis without requiring IPD.